Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.
Liu X, Bai Y, Wang T, Song Y, Sun F, Xia R, Zhu F, Ma J, Lu Q, Ye X, Zhan X, Li L, Guo X, Cheng S, Li Y, Guo Z, Chen Y, Qian S, Qin L, Zhang Q, Cao S, Yang R.
Liu X, et al. Among authors: li y, li l.
Platelets. 2023 Dec;34(1):2157806. doi: 10.1080/09537104.2022.2157806.
Platelets. 2023.
PMID: 36597010
Free article.
Clinical Trial.